Altemeier William A, Zhu Xiaodong, Berrington William R, Harlan John M, Liles W Conrad
Department of Medicine, University of Washington School of Medicine, 1959 NE Pacific St., Seattle, WA 98105-6522, USA.
J Leukoc Biol. 2007 Sep;82(3):721-8. doi: 10.1189/jlb.1006652. Epub 2007 Jun 18.
Activation of the prototypical death receptor, Fas (CD95), can induce both caspase-dependent cell death and production of proinflammatory chemokines, leading to neutrophil recruitment and end-organ injury. The precise mechanism(s) by which Fas up-regulates chemokine production and release, is currently unclear. We hypothesized that Fas-induced chemokine release by macrophages is dependent on the MyD88 adaptor molecule and independent of caspase activity. To test this hypothesis, we measured chemokine response to Fas activation both in RAW 264.7 cells with RNAi-attenuated MyD88 expression and in MyD88-deficient primary macrophages. We found that Fas-induced chemokine release was abrogated in the absence of MyD88. In vivo, MyD88(-/-) mice had impaired CXCL1/KC release and polymorphonuclear cell recruitment in response to intratracheal treatment with the Fas-activating monoclonal antibody, Jo-2. Furthermore, Fas-induced chemokine release was not dependent on either IL-1 receptor signaling or on caspase activity. We conclude that MyD88 plays an integral role in Fas-induced macrophage-mediated inflammation.
典型死亡受体Fas(CD95)的激活可诱导半胱天冬酶依赖性细胞死亡以及促炎趋化因子的产生,从而导致中性粒细胞募集和终末器官损伤。目前尚不清楚Fas上调趋化因子产生和释放的确切机制。我们推测巨噬细胞中Fas诱导的趋化因子释放依赖于MyD88衔接分子且独立于半胱天冬酶活性。为验证这一假设,我们在RNA干扰减弱MyD88表达的RAW 264.7细胞以及MyD88缺陷的原代巨噬细胞中测量了趋化因子对Fas激活的反应。我们发现,在缺乏MyD88的情况下,Fas诱导的趋化因子释放被消除。在体内,MyD88(-/-)小鼠在经Fas激活单克隆抗体Jo-2气管内治疗后,CXCL1/KC释放受损且多形核细胞募集减少。此外,Fas诱导的趋化因子释放既不依赖于IL-1受体信号传导,也不依赖于半胱天冬酶活性。我们得出结论,MyD88在Fas诱导的巨噬细胞介导的炎症中起不可或缺的作用。